The Use of CDK Inhibitors in Oncology: A Pharmaceutical Perspective
- 1 June 2004
- journal article
- review article
- Published by Taylor & Francis in Cell Cycle
- Vol. 3 (6) , 740-744
- https://doi.org/10.4161/cc.3.6.937
Abstract
To date dozens of pharmacophores with CDK-inhibitory properties have been discovered and the first compounds possessing such activity are now under clinical evaluation. Because the real therapeutic...Keywords
This publication has 0 references indexed in Scilit: